Print ISSN: 2581-5210
Online ISSN: 2581-5229
CODEN : IIJAAL
IP Indian Journal of Anatomy and Surgery of Head, Neck and Brain (IJASHNB) open access, peer-reviewed quarterly journal publishing since 2015 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better dissemination of knowledge, we will be publishing more...Review Article
Author Details :
Volume : 8, Issue : 2, Year : 2022
Article Page : 51-56
https://doi.org/10.18231/j.ijashnb.2022.013
Abstract
Nasopharyngeal carcinoma (NPC) is a rare type of tumor which arises from the surface and lining epithelium of nasopharynx. Management of nasopharyngeal carcinoma is one of the greatest clinical challenges but it is radiosensitive and chemosensitive; excellent tumor control can be attained with radiotherapy with or without adjuvant therapies concurrent chemoradiation therapy. This review will focus on role of neoadjuvant chemotherapy in nasopharyngeal carcinoma on disease free survival (DFS), distant metastases free survival and overall survival (OS) and systemic toxicities, indications and choice and number of cycles of regimen for neoadjuvant chemotherapy.
Keywords: Nasopharyngeal Carcinoma, Nasopharynx, Chemotherapy, Radiation Therapy, Concurrent Chemoradiotherapy, CCRT, NPC
How to cite : Pawar P, Bhandari P, Bihani A, Gupta K, Sethjiwala T, Role of neo-adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma. IP Indian J Anat Surg Head Neck Brain 2022;8(2):51-56
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.